Vanguard Group Inc Editas Medicine, Inc. Transaction History

Vanguard Group Inc

  • $5.97 Trillion
  • Q2 2025

A detailed history of Vanguard Group Inc transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 7,159,492 shares of EDIT stock, worth $27.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,159,492
Previous 7,466,254 4.11%
Holding current value
$27.2 Million
Previous $8.66 Million 81.87%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
SELL
$0.98 - $2.35 $300,626 - $720,890
-306,762 Reduced 4.11%
7,159,492 $15.8 Million
Q1 2025

May 09, 2025
BUY
$1.14 - $3.2 $733,311 - $2.06 Million
643,256 Added 9.43%
7,466,254 $8.66 Million
Q4 2024

Feb 11, 2025
BUY
$1.2 - $3.76 $172,070 - $539,153
143,392 Added 2.15%
6,822,998 $8.67 Million
Q3 2024

Nov 13, 2024
SELL
$3.39 - $5.96 $4.59 Million - $8.06 Million
-1,352,998 Reduced 16.84%
6,679,606 $22.8 Million
Q2 2024

Aug 13, 2024
SELL
$4.67 - $7.28 $2.44 Million - $3.81 Million
-522,993 Reduced 6.11%
8,032,604 $37.5 Million
Q1 2024

May 10, 2024
BUY
$7.03 - $11.07 $658,992 - $1.04 Million
93,740 Added 1.11%
8,555,597 $63.5 Million
Q4 2023

Feb 14, 2024
SELL
$6.25 - $11.11 $464,693 - $826,039
-74,351 Reduced 0.87%
8,461,857 $85.7 Million
Q3 2023

Nov 14, 2023
BUY
$6.92 - $9.31 $2.57 Million - $3.45 Million
370,734 Added 4.54%
8,536,208 $66.6 Million
Q2 2023

Aug 14, 2023
BUY
$6.36 - $11.47 $6.12 Million - $11 Million
962,760 Added 13.37%
8,165,474 $67.2 Million
Q1 2023

Jul 14, 2023
BUY
$7.03 - $11.53 $21,090 - $34,590
3,000 Added 0.04%
7,202,714 $52.2 Million
Q1 2023

May 15, 2023
BUY
$7.03 - $11.53 $2.3 Million - $3.77 Million
326,591 Added 4.75%
7,199,714 $52.2 Million
Q4 2022

Feb 10, 2023
BUY
$8.32 - $13.21 $1.23 Million - $1.95 Million
147,783 Added 2.2%
6,873,123 $61 Million
Q3 2022

Nov 14, 2022
BUY
$12.16 - $19.42 $1.09 Million - $1.74 Million
89,730 Added 1.35%
6,725,340 $82.3 Million
Q2 2022

Aug 12, 2022
SELL
$9.99 - $21.35 $2.41 Million - $5.14 Million
-240,929 Reduced 3.5%
6,635,610 $78.5 Million
Q1 2022

May 13, 2022
BUY
$14.08 - $27.63 $2.85 Million - $5.6 Million
202,642 Added 3.04%
6,876,539 $131 Million
Q4 2021

Feb 14, 2022
BUY
$26.55 - $40.57 $6.13 Million - $9.36 Million
230,747 Added 3.58%
6,673,897 $177 Million
Q3 2021

Nov 12, 2021
SELL
$39.27 - $72.94 $1.6 Million - $2.97 Million
-40,782 Reduced 0.63%
6,443,150 $265 Million
Q2 2021

Aug 13, 2021
BUY
$31.29 - $56.64 $203 Million - $367 Million
6,483,932 New
6,483,932 $367 Million

Others Institutions Holding EDIT

# of Institutions
217
Shares Held
45.5M
Call Options Held
476K
Put Options Held
338K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $261M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email